Literature DB >> 3850106

Antitumor activity and toxicity of peroxo heteroligand vanadates(V) in relation to biochemistry of vanadium.

C Djordjevic, G L Wampler.   

Abstract

A selected set of 14 V(V) complexes was tested for toxicity and antitumor activity against L1210 murine leukemia, to examine the biological properties of peroxoheteroligand vanadates(V) of the formula (NH4)4[O(VO(O2)2)2], M3I[VO(O2)2C2O4], and MI[VO(O2)L], L = malate, citrate, iminodiacetate, nitrilotriacetate, and EDTA. The x-ray structure is known for five of these compounds. A relationship has been found between the chemical composition and the biological activity (antitumor activity-toxicity) of these complexes. Activity in the L1210 system is defined as greater than or equal to 25% increase in life span, and this was seen with (NH4)4[O(VO(O2)2)2]; M3[VO(O2)2(C2O4)]2H2O, M = K, NH4; and NH4[VO(O2)Malato]H2O. These observations are important for the biochemistry of vanadium. The special nature of electron transfer within the V(V)-peroxo moiety is proposed to be responsible for this phenomenon. Peroxo heteroligand vanadates(V) therefore represent a model system for studying some biochemical interactions of vanadium in living matter.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3850106     DOI: 10.1016/0162-0134(85)83007-5

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  10 in total

1.  Oxidovanadium(IV) complexes with chrysin and silibinin: anticancer activity and mechanisms of action in a human colon adenocarcinoma model.

Authors:  I E León; J F Cadavid-Vargas; I Tiscornia; V Porro; S Castelli; P Katkar; A Desideri; M Bollati-Fogolin; S B Etcheverry
Journal:  J Biol Inorg Chem       Date:  2015-09-24       Impact factor: 3.358

2.  Peroxo heteroligand vanadates(V): synthesis, spectra-structure relationships, and stability toward decomposition.

Authors:  C Djordjevic; N Vuletic; M L Renslo; B C Puryear; R Alimard
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 3.  The chemistry of peroxovanadium compounds relevant to insulin mimesis.

Authors:  A Shaver; J B Ng; D A Hall; B I Posner
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

4.  Chemically and photochemically initiated DNA cleavage by an insulin-mimetic bisperoxovanadium complex.

Authors:  C Hiort; J Goodisman; J C Dabrowiak
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

5.  Multiple reactions in vanadyl-V(IV) oxidation by H2O2.

Authors:  H N Shankar; T Ramasarma
Journal:  Mol Cell Biochem       Date:  1993-12-08       Impact factor: 3.396

6.  Antiproliferative and apoptosis-inducing activity of an oxidovanadium(IV) complex with the flavonoid silibinin against osteosarcoma cells.

Authors:  I E Leon; V Porro; A L Di Virgilio; L G Naso; P A M Williams; M Bollati-Fogolín; S B Etcheverry
Journal:  J Biol Inorg Chem       Date:  2014-01       Impact factor: 3.358

7.  DNA modification by oxovanadium(IV) complexes of salen derivatives.

Authors:  Géraldine Verquin; Gaëlle Fontaine; Marc Bria; Elena Zhilinskaya; Edmond Abi-Aad; Antoine Aboukaïs; Brigitte Baldeyrou; Christian Bailly; Jean-Luc Bernier
Journal:  J Biol Inorg Chem       Date:  2004-03-13       Impact factor: 3.358

Review 8.  Anticancer activity of metal complexes: involvement of redox processes.

Authors:  Ute Jungwirth; Christian R Kowol; Bernhard K Keppler; Christian G Hartinger; Walter Berger; Petra Heffeter
Journal:  Antioxid Redox Signal       Date:  2011-05-11       Impact factor: 8.401

9.  Inhibitory effect of vanadium on rat liver carcinogenesis initiated with diethylnitrosamine and promoted by phenobarbital.

Authors:  A Bishayee; M Chatterjee
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

Review 10.  Vanadium compounds in medicine.

Authors:  Joao Costa Pessoa; Susana Etcheverry; Dinorah Gambino
Journal:  Coord Chem Rev       Date:  2014-12-09       Impact factor: 22.315

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.